Topiramate for Headaches and Anxiety
Topiramate is FDA-approved and strongly recommended for migraine prevention, but it is NOT approved or recommended for anxiety treatment—in fact, anxiety is listed as a common adverse effect of the medication. 1
Migraine Prevention: Strong Evidence
Topiramate is a first-line option for episodic migraine prevention according to the 2025 American College of Physicians guidelines 2. The evidence supporting its use for headache prevention is robust:
Efficacy for Migraines
- Reduces migraine frequency by 2-3 days per month compared to placebo in multiple randomized controlled trials 3, 4
- Effective for both episodic migraine (fewer than 15 headache days/month) and chronic migraine (15 or more headache days/month) 5, 4
- Responder rates of 39-49% (patients achieving ≥50% reduction in migraine frequency) at doses of 50-200 mg/day 3
- Benefits typically appear within the first month of treatment 3
Dosing for Migraine Prevention
- Target dose: 100 mg/day for migraine prophylaxis 2, 1
- Start at 25 mg/day and titrate upward by 25 mg weekly to minimize side effects 5, 3
- Dosing range: 50-200 mg/day depending on tolerability and response 1
Anxiety: Not an Indication—Actually a Side Effect
Topiramate should NOT be used to treat anxiety. The FDA drug label explicitly lists anxiety as a dose-related adverse event occurring in 6-10% of patients 1. Additional psychiatric side effects include:
- Nervousness (13-19% at higher doses)
- Depression (7-13%)
- Mood problems (6-9%)
- Difficulty with concentration/attention 1
Important Safety Considerations
The FDA label warns about serious psychiatric effects 1:
- Depression or mood problems
- Suicidal thoughts or behavior
- Cognitive impairment (confusion, difficulty with memory, psychomotor slowing)
Patients with pre-existing depression, mood problems, or anxiety should be monitored closely if topiramate is prescribed for migraine prevention 1.
Common and Serious Side Effects
Most Common (Generally Manageable)
- Paresthesia (tingling): 28-53% of patients, but rarely causes discontinuation 1, 6
- Fatigue, somnolence, dizziness
- Weight loss (often desired in migraine patients)
- Anorexia, nausea, taste changes 1
Serious Adverse Effects Requiring Monitoring
- Metabolic acidosis: Monitor serum bicarbonate levels 1
- Acute angle-closure glaucoma: Sudden vision loss or eye pain requires immediate evaluation 1
- Kidney stones: Ensure adequate hydration (migraineurs already at increased risk) 1, 6
- Cognitive impairment: Can often be managed by slower titration 6
- Teratogenicity (Pregnancy Category D): Increased risk of cleft lip/palate with first-trimester exposure 1, 6
Clinical Bottom Line
For migraine prevention: Yes, topiramate is highly effective and guideline-recommended. Start at 25 mg/day, titrate slowly to 100 mg/day, and monitor for cognitive and psychiatric side effects 2, 1, 3.
For anxiety: No, do not use topiramate. It can worsen anxiety and cause other psychiatric symptoms 1. If a patient needs both migraine prevention and anxiety treatment, consider alternative migraine preventives (such as propranolol, which may help both conditions) or treat anxiety separately with appropriate anxiolytic medications.
Key Pitfall to Avoid
Do not assume topiramate's mood-stabilizing properties in epilepsy translate to anxiety treatment in migraine patients—the evidence shows the opposite effect, with anxiety being a common adverse event 1.